Xueyong Zhu

Scripps Research Institute — United States

Medicine · Health Sciences

54h-index12.6kcitations137works10.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(48), SARS-CoV-2 and COVID-19 Research(36), Monoclonal and Polyclonal Antibodies Research(36), Viral gastroenteritis research and epidemiology(20), Respiratory viral infections research(20)

Publications137 total

VHH antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusion
npj Viruses·2025Open Access
Single-component self-assembling protein nanoparticles displaying stabilized prefusion-closed hemagglutinin trimers for influenza vaccine development
2025Open Access
Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation
Communications Biology·2025Open Access
Human monoclonal antibodies targeting A35 protect from death caused by mpox
Cell·2025· 10 citedOpen Access
Characterization of ambient seismic noise in Alaska
Marine Geophysical Research·2025
Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation
2025Open Access
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
Cell Reports·2025· 7 citedOpen Access
The receptor binding properties of H5Nx influenza A viruses have evolved to promiscuously bind to avian-type mucin-like O-glycans
2025· 1 citedOpen Access
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors
Proceedings of the National Academy of Sciences·2025· 5 citedOpen Access
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins
Immunity·2025· 9 citedOpen Access
Structural and Mechanistic Insights into Disease-associated Endolysosomal Exonucleases PLD3 and PLD4
Structural Dynamics·2025Open Access
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens
Proceedings of the National Academy of Sciences·2025· 1 citedOpen Access
Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genes
Nature Communications·2025· 7 citedOpen Access
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors
2025· 1 citedOpen Access
Performance-Based Classification of Industrial Flocculent Cellulose Fibers Using Multi-Index Testing, Principal Component Analysis, and K-Means Clustering
Advances in engineering research/Advances in Engineering Research·2025
A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors
Science·2024· 112 citedOpen Access
Plant‐produced <scp>SARS</scp>‐<scp>CoV</scp>‐2 antibody engineered towards enhanced potency and in vivo efficacy
Plant Biotechnology Journal·2024· 2 citedOpen Access
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry
Proceedings of the National Academy of Sciences·2024· 16 citedOpen Access
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4
Structure·2024· 10 citedOpen Access
Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site
Cell Host & Microbe·2024· 32 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Ian A. Wilson(46), Wenli Yu(19), Meng Yuan(15), Nicholas C. Wu(14), James C. Paulson(14), Ryan McBride(12), Andrew B. Ward(12), Chang‐Chun D. Lee(10), Hejun Liu(10), Dennis R. Burton(8), Sandhya Bangaru(8), Linghang Peng(7), David Nemazee(7), Deli Huang(6), Rogier W. Sanders(6), Richard A. Lerner(6), Robert P. de Vries(6), Marit J. van Gils(5), Hannah L. Turner(5), James E. Crowe(5)